LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China flag China · Delayed Price · Currency is CNY
8.30
-0.19 (-2.24%)
Jun 18, 2025, 3:04 PM CST

SHE:002644 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Operating Revenue
919.24977.451,1581,041809.39659.96
Upgrade
Other Revenue
2.782.785.451.588.258.09
Upgrade
Revenue
922.02980.231,1631,042817.64668.05
Upgrade
Revenue Growth (YoY)
-17.60%-15.73%11.58%27.49%22.39%6.24%
Upgrade
Cost of Revenue
634.48681.46804.17738.23596.57503.63
Upgrade
Gross Profit
287.54298.76358.96304.16221.07164.42
Upgrade
Selling, General & Admin
174.03184.21236.74181.6131.27119.61
Upgrade
Research & Development
30.1429.2830.9323.5619.3615.38
Upgrade
Other Operating Expenses
16.8111.3713.3214.5314.8212.04
Upgrade
Operating Expenses
250.78254.63296.07238.06175.42151.14
Upgrade
Operating Income
36.7644.1362.966.145.6513.28
Upgrade
Interest Expense
-0.83-0.83-1.24-1.35-0.95-1.28
Upgrade
Interest & Investment Income
5.745.745.377.5110.212.82
Upgrade
Currency Exchange Gain (Loss)
0.30.31.082.15-0.33-0.37
Upgrade
Other Non Operating Income (Expenses)
-3.44-3.95-1.43-17.88-1.220.89
Upgrade
EBT Excluding Unusual Items
38.5345.3866.6756.5353.3625.34
Upgrade
Gain (Loss) on Sale of Investments
-5.64-7.23-4.49-1.3-0.85-4.05
Upgrade
Gain (Loss) on Sale of Assets
0.040.04-027.1870.59
Upgrade
Asset Writedown
---0-0.2-0.370.15
Upgrade
Legal Settlements
----0.01-
Upgrade
Other Unusual Items
37.3330.9419.4675.6831.4838.48
Upgrade
Pretax Income
70.2769.1481.64130.72110.81130.52
Upgrade
Income Tax Expense
7.127.4713.5221.3717.322.81
Upgrade
Earnings From Continuing Operations
63.1561.6768.12109.3593.52107.71
Upgrade
Minority Interest in Earnings
-2.08-1.6-0.93-0.69-0.260.31
Upgrade
Net Income
61.0660.0767.19108.6593.26108.02
Upgrade
Net Income to Common
61.0660.0767.19108.6593.26108.02
Upgrade
Net Income Growth
-0.97%-10.60%-38.16%16.51%-13.66%44.31%
Upgrade
Shares Outstanding (Basic)
511511511511511511
Upgrade
Shares Outstanding (Diluted)
511511511511511511
Upgrade
Shares Change (YoY)
0.02%0.05%-0.01%-0.03%0.00%0.03%
Upgrade
EPS (Basic)
0.120.120.130.210.180.21
Upgrade
EPS (Diluted)
0.120.120.130.210.180.21
Upgrade
EPS Growth
-0.99%-10.64%-38.16%16.54%-13.66%44.27%
Upgrade
Free Cash Flow
44.1225.743.2445.08-20.95-59.69
Upgrade
Free Cash Flow Per Share
0.090.050.090.09-0.04-0.12
Upgrade
Dividend Per Share
0.0120.0120.0300.0500.0100.120
Upgrade
Dividend Growth
-60.00%-60.00%-40.00%400.00%-91.67%100.00%
Upgrade
Gross Margin
31.19%30.48%30.86%29.18%27.04%24.61%
Upgrade
Operating Margin
3.99%4.50%5.41%6.34%5.58%1.99%
Upgrade
Profit Margin
6.62%6.13%5.78%10.42%11.41%16.17%
Upgrade
Free Cash Flow Margin
4.78%2.62%3.72%4.32%-2.56%-8.94%
Upgrade
EBITDA
85.9593.76114.29114.9693.5858.42
Upgrade
EBITDA Margin
9.32%9.56%9.83%11.03%11.45%8.74%
Upgrade
D&A For EBITDA
49.1949.6351.3948.8647.9245.13
Upgrade
EBIT
36.7644.1362.966.145.6513.28
Upgrade
EBIT Margin
3.99%4.50%5.41%6.34%5.58%1.99%
Upgrade
Effective Tax Rate
10.13%10.81%16.56%16.35%15.61%17.48%
Upgrade
Revenue as Reported
922.02980.231,1631,042817.64668.05
Upgrade
Advertising Expenses
-7.6837.8622.2915.7322.32
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.